The University of Sydney
spcr
spcr

Associate Professor Jasmine Henderson

E: jasmine.henderson@bosch.org.au
T: +61 2 9036 9408
F: +61 2 9351 3868
D06 - Blackburn Building
The University of Sydney
NSW 2006 Australia

Publications

2009

Leaver, K, Allbutt, H, Creber, N, Kassiou, M, Henderson, J. Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection. Brain Research Bulletin. 2009; 80:397-402
Henderson, J, Lanciego, J, Smith, Y, Gundlach, A, Kassiou, M, , O. Proceedings of the 2007 International Brain Research Organisation Satellite Meeting "Movement Disorders: Focus on the Thalamus and Basal Ganglia" held in Sydney, Australia, 10-11 July, 2007. Brain research bulletin. 2009; 78:53-4
Truong, L, Allbutt, H, Coster, M, Kassiou, M, Henderson, J. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions. Brain research bulletin. 2009; 78:91-6
Warraich, S, Allbutt, H, Billing, R, Radford, J, Coster, M, Kassiou, M, Henderson, J. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model. Brain research bulletin. 2009; 78:85-90
Johnson, M, Sharma, M, Jamieson, C, Henderson, J, Mok, M, Bendall, L, Henderson, B. Regulation of beta-catenin trafficking to the membrane in living cells. Cellular signalling. 2009; 21:339-48

2008

van Dijk, A, Johnston, C, Allbutt, H, Kassiou, M, Henderson, J. Behavioural effects of trishomocubanes in rats with unilateral 6-hydroxydopamine lesions. Behavioural Brain Research. 2008; 190:14-21
Lee, J, Zhu, W, Stanic, D, Finkelstein, D, Horne, M, Henderson, J, Lawrence, A, O'Connor, L, Tomas, D, Drago, J, Horne, M. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia. Brain : a journal of neurology. 2008; 131:1574-87

2007

Oehrn, C, Allbutt, H, Henderson, J. Effect of ventrolateral thalamic nucleus lesions in the unilateral 6-hydroxydopamine rat model. Behavioural brain research. 2007; 183:67-77
Quinlivan, M, Chalon, S, Vergote, J, Henderson, J, Katsifis, A, Kassiou, M, Guilloteau, D. Decreased vesicular acetylcholine transporter and alpha(4)beta(2) nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning. Neuroscience letters. 2007; 415:97-101
Allbutt, H, Henderson, J. Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease. Journal of neuroscience methods. 2007; 159:195-202

2006

Sharma, M, Leung, L, Brocardo, M, Henderson, J, Flegg, C, Henderson, B. Membrane localization of adenomatous polyposis coli protein at cellular protrusions: targeting sequences and regulation by beta-catenin. The Journal of biological chemistry. 2006; 281:17140-9
Henderson, J, Doherty, K, Allbutt, H, Billing, R. Effects of pallidotomy on motor symptoms in an animal model of Parkinson's disease. Behavioural brain research. 2006; 169:29-38
Truong, L, Allbutt, H, Kassiou, M, Henderson, J. Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions. Behavioural brain research. 2006; 169:1-9

2005

Schleimer, S, Johnston, G, Henderson, J. Novel oral drug administration in an animal model of neuroleptic therapy. Journal of neuroscience methods. 2005; 146:159-64
Henderson, J, Schleimer, S, Allbutt, H, Dabholkar, V, Abela, D, Jovic, J, Quinlivan, M. Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism. Behavioural brain research. 2005; 162:222-32
Henderson, J. The thalamus and Parkinson's disease: clinical, pathologiucal and experimental observations. In: . : 2005. p. .
Henderson, J. The thalamus and Parkinson's disease: clinical, pathological and experimental observations. In: . : 2005. p. .
Henderson, J, Macdonald, V, Halliday, G. Thalamic And Cortical Changes in Parkinsonian Disorders. The Basal Ganglia VIII. 2005; Scotland 5-9 September; 2005
Henderson, J. The thalamus and Parkinson's disease: clinical, pathological and experimental observations. In: Scientific Basis for the Treatment of Parkinson's Disease. United Kingdom: Taylor & Francis 2005. p. 105-114.

2004

Henderson, J, Rodriguez, M, O'Sullivan, D, Pell, M, Fung, V, Benabid, A, Halliday, G. Partial lesion of thalamic ventral intermediate nucleus after chronic high-frequency stimulation. Movement disorders : official journal of the Movement Disorder Society. 2004; 19:709-11

2003

Double, K, Halliday, G, Henderson, J, Griffiths, F, Heinemann, T, Riederer, P, Gerlach, M. The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration. Experimental Neurology. 2003; 184 (2003):530-535

2002

Henderson, J, Pan, Y, Britt, H, Charles, J, Miller, G, Knox, S. Cardiovascular problems and risk behavious among patients at general practice encounters in Australia 1998-00. Canberra: Australian Institute of Health and Welfare Media and Publishing Unit, 2002.
Britt, H, Miller, G, Knox, S, Charles, J, Valenti, L, Henderson, J, Pan, Y, Sutton, C, Harrison, C. General Practice Activity in Australia 2001-02. Canberra: Australian Institute of Health and Welfare Media and Publishing Unit, 2002.
[Show earlier publications]
spcr
Print Friendly VersionPrinter format
spcr
Email a FriendEmail to a friend
spcr
Large text
spcr
Default text
spcr
textsize
spcr

spcr
spcr